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The link between gut microbiota and insulin resistance has an important clinical impact, people 
affected by dysbiosis having a predisposition for developing: obesity, type 2 diabetes mellitus, non-
alcoholic fatty liver disease, cancers, cardiovascular, neurodegenerative and psychiatric diseases. 
Dysbiosis may lead through chronic inflammation to obesity and metabolic syndrome. We carried 
out a systematic review of the studies dedicated to the role of gut microbiota in weight gain and 
obesity. A systematic literature search of recent data published in electronic databases, was 
performed, using as search phrase: "gut microbiome and body weight and obesity". Studies that 
contained no data about the influence of gut microbiota changes on obesity were excluded. Western 
diet, antibiotic use in childhood, excessive maternal pre-pregnancy weight, Cesarean delivery, and 
testosterone deficiency are triggers of the alteration of microbiota and subsequently the appearance 
of obesity. Predominance of Firmicutes and anaerobic genera, changes in the mycobiome and viral 
intestinal population are implied in the etiology of obesity. Prebiotics, polyphenols, different herbs, 
medication (antidiabetics, calcium), physical exercise, rich fibre intake and bariatric surgery are the 
most important therapeutic options. Personalized dietary treatments, antiviral agents and 
mycobiome manipulation would represent the new target in treating obesity. Any change of the 
quantitative and qualitative composition of microbiota has influence on the components of 
metabolic syndrome, so any management strategy for the treatment or prevention of obesity in 
children and adulthood should have the microbiome as target.  
 






Gut microbiota actually represents an active biomass, from a metabolic point of 
view, any change in the composition and/or abundances of different bacterial species 
may predict the progression toward metabolic syndrome. It has an important role in 
maintaining homeostasis; although the direct relationship between microbiota and 
various disorders is still unclear, predominance of some phyla and quantitative and 
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both qualitative imbalance of different species has an important impact on creating a 
chronic inflammatory state, which leads to obesity and diabetes. The human 
gastrointestinal microbiota consists of 1014 microorganisms/ml of luminal content, 
belonging to over 5000 bacterial species, 90% of them belong to the Bacteroidetes 
phyla. The link between gut microbiota and insulin resistance has an important 
clinical impact, people affected by dysbiosis have a predisposition for developing: 
obesity, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease 
(NAFLD), cardiovascular, neurodegenerative and psychiatric diseases (mental 
illness, dementia, depression), cancers (gastric, colorectal, esophageal, liver and 
pancreatic carcinomas) (Bruce-Keller et al., 2015; Koh et al., 2016; Saad, Santos, & 
Prada, 2016). The aim of this paper is to review the mechanisms of implication of 
microbiota in obesity, as well as the possible therapeutic strategies beneficial to lose 
weight, and to prevent/treat the components of metabolic syndrome by acting on the 
microbiome. The importance of microbiota implication in obesity has been described 
in different reviews up to now, among them the most important are: Saad et al. 
(2016), Oh, Ahn, and Cho (2016), Nehra, Allen, Mailing, Kashyap, and Woods 





A systematic literature search of recent data published in electronic databases, 
including PubMed and ISI Web of Science, was performed for all studies assessing 
the influence of gut microbiota changes on obesity (from 1st January 2015 to 1st 
October 2017). The search strategy included text terms and Medical Subject 
Headings (MeSH) for microbiota and obesity: "gut microbiome and body weight and 
obesity". The "related articles" function in PubMed was also used to identify articles 




The inclusion criteria used were: abstracts and full-text journal publication, 
including data about pathogenetic mechanisms of gut microbiota in inducing obesity, 
and treatment options in the metabolic syndrome. Papers in English, French, German 
and Polish were included in the study, or in any other language, but with an English 
abstract. The titles and abstracts of all identified studies were reviewed and then 
confronted by independent authors (between 1st January 2015 to 31st December 2016 
by: ID and FR, and between 1st January 2016 to 1st October 2017 by: AC and DLD) 
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Studies were excluded if they were editorials or letters to the editor, or did not 
meet the inclusion criteria; these were papers containing general literature data about 
gut microbiota and obesity, but without mentioning any study or any precise 





The first search resulted in a total of 201 articles. After reviewing the abstracts, 
we kept 184 studies, which described the mechanisms of the gut microbiota 
implication in obesity and therapeutic options and thus met our inclusion criteria. 
Included articles were published between 1st January 2015 and 1st October 2017. The 
17 excluded articles mentioned the implication of gut microbiota in obesity in 





Figure 1. The Selection of Papers for this Analysis. 
 
 




Davis, Yadav, Barrow, and Robertson (2017) showed that Westernized diet 
proved to be a more severe factor in causing dysbiosis as compared to an overweight 
or obese body mass index (BMI). One of the important triggers of childhood obesity 
is the antibiotic use, which increases the adipogenesis and alters the microbiota 
composition (Li, Wang, et al., 2017).  
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Note. NR = not reported; ODMA = O-desmethylangolensin; OUT = operational bacterial taxonomic 
units; IMAO = trimethylamine-N-oxide; MUFA = mono-unsaturated fatty acid; PUFA = 
polyunsaturated fatty acids. 
 
Table 1 described human studies that concerned different types of species of 
microbiota and their change in children and adults, but also their impact on weight 
gain, diabetes mellitus and cardiovascular diseases.  
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O-desmethylangolensin (ODMA) non-producer phenotype (individuals that are 
not capable of metabolizing the soy isoflavone daidzein to ODMA) was associated 
with obesity in peri- and post-menopausal women (Miller et al., 2017).  
Non-alcoholic liver fatty disease (NAFLD) combined with portal vein toxins 
secondary to an altered microbiota led to early occurrence of non-alcoholic 
steatohepatitis (NASH) in children, through the following mechanisms: increasing 
obesity in children, gut-liver-axis-dysfunction, perturbations of trace element 
homeostasis, and oxidative stress due to genetic changes – allele substitution in the 
PNPLA3 gene (Betancourt-Garcia et al., 2017; Clemente, Mandato, Poeta, & Vajro, 
2016).  
 
Gut Changes in Pregnancy 
 
Excessive maternal pre-pregnancy weight associated with vaginal delivery 
leads to altered microbiota of the child and consequently an altered metabolism 
(Mueller et al., 2016). Cesarean delivery was associated with a higher BMI but there 
was no correlation found with glucose, insulin resistance, cholesterolemia and 
triglyceridemia levels in a Brazilian study (Bernardi et al., 2015). Caesarean section-
born children without a pet animal at home had a higher risk of obesity at the age of 
2 years, without knowing the exact mechanism (Cassidy-Bushrow et al., 2015). 
Higher risk of neurodevelopmental disorders in children, including autism, has been 
associated with maternal obesity during pregnancy (Buffington et al., 2016). Dietary 
strategies including early nutritional exposures, with more tolerogenic conditions 
during early immune programming in small children reduces the risk of allergies and 
many inflammatory diseases (Prescott, 2016).  
 
Gut Compositional Changes in Humans 
 
Ignacio et al. (2016) showed that lean individuals have higher abundance of 
Bifidobacterium spp. compared with obese persons. Rich diet in unsaturated fatty 
acids and fibre induces in young adults abundant beneficial microbiota population, 
like B.longum and Bacteroidetes (Mayorga Reyes et al., 2016). Predominance of 
Firmicutes and anaerobic genera over the Bacteroidetes and Actinobacteria strains 
were found in obese children (Angelakis et al., 2015; Barczynska, Slizewska, Litwin, 
Szalecki, & Kapusniak, 2016). Central adiposity in young obese people had a 
corresponding subclinical endotoxemia (measured by serum lipopolysacharides 
concentration) with small amount of E.coli and hypertrygliceridemia (Radilla-
Vázquez et al., 2016). Not only bacterial population is implied, but specific fungal 
composition of microbiota (mycobiome) was proven also to have importance in 
weight gain, Mucor racemosus and M. fuscus being more abundant in lean people 
(Mar Rodríguez et al., 2015). 
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High diversity of microbiota, together with fiber intake and operational bacterial 
taxonomic units (OTUs), like Ruminococcaceae and Lachnospiraceae, proved to be 
associated with lower risk of weight gain in humans, independently of the caloric 
intake (Menni et al., 2017). Moreno-Indias et al. (2016) showed that moderate intake 
of red wine improved weight gain. Recent studies revealed that intake of selected 
psychobiotics modulated microbiota in preobese and obese women, but further 
research is needed in order to establish exact correlations (De Lorenzo et al., 2017). 
For children and adults, fecal transplantation represents a new way of managing 
severe obesity (Jayasinghe, Chiavaroli, & Holland, 2016).  
Bariatric surgery represents the main option in morbid obesity. Gut microbioma 
diversity increased within the first 3 months after Roux-en-Y-gastric bypass surgery 
in obese patients, remaining high even one year later (Palleja et al., 2016). 
 
 




Noble et al. (2017) showed that especially early-life sugar consumption alters 
in rats the microbiota, independently of caloric intake, body weight or adiposity 
index. Artificial sweeteners, like saccharin and acesulfame-potassium disturbs the 
gut microbiota in mice inducing glucose intolerance, raising questions about their 
possible contribution to the epidemic of obesity and diabetes (Bian et al., 2017). 
Hypogonadism and androgen deprivation (castration) altered the cecal and fecal 
microbiota, increased plasma adiponectin irrespective of diet, and increased the risk 
factors for cardiovascular disease (obesity, impaired fasting glucose, high 
triglyceride amount in liver, muscle weight loss) in high-fat diet-fed mice (Harada, 
Hanaoka, Hanada, et al., 2016); testosterone deficiency altered the intestinal 
microbiome in mice, inducing abdominal obesity (Harada, Hanaoka, Horiuchi et al., 
2016).  
Table 2 described animals' experimental studies that concerned several types of 
species of microbiota and the change induced by different types of diet, but also the 
impact of pre/probiotics on weight gain and obesity reduction. 
Experimental studies on mice showed that deficiency of intestinal mucin-2 and 
higher IL-22 levels offer protection from diet-induced NAFL and obesity (Hartmann 
et al., 2016). In line with human studies, hypogonadism represents also in mice a 
responsible factor for inducing cardiovascular diseases (Harada, Hanaoka, Hanada 
et al., 2016).  
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Table 2  
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Gut Composition Changes in Animals 
 
Greater abundance of Firmicutes and lower of Bacteroidetes, decreased 
Bacteroidetes/Firmicutes ratio and increased Bacteroides/Prevotella ratio were 
found in high-protein, low-carbohydrate (HPLC) diet-fed dogs; microbial gene 
networks were enriched by using HPLC diet, maintaining weight in dogs (Li, Lauber, 
Czarnecki-Maulden, Pan, & Hannah, 2017). Another beneficial bacteria, implied in 
metabolism, is Akkermansia muciniphila; its abundance is affected by age and high-
fat diet (Schneeberger et al., 2015). It was proven that obese subjects have an 




Many substances targeting the microbiota, like probiotics (live bacteria), 
prebiotics (oligosaccharides) and synbiotics (pre- and probiotics) have been found to 
have the capability of acting in order to prevent/treat obesity (Kieffer et al., 2016).  
Studies on mice proved that Berberine, a Chinese herb, has lipid lowering effect, 
through several mechanisms: inhibition of bile salt hydrolase activity, increasing the 
taurocholic-acid, activation of intestinal farnesoid-X receptor and reduction of long-
chain-fatty acid-uptake in the liver (Ziętak, Chabowska-Kita, & Kozak, 2017). 
Beneficial effects, obtained in rats by reduction of microbial diversity of the host, can 
be achieved by administration of Berberine in combination with Metformin (Zhang 
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et al., 2015). Among prebiotics, dietary lipid absorbent-montmorillonite (DLA-M) 
seems to prevent dysbiosis and obesity-related metabolic disorders by absorbing free 
fatty acids and endotoxins (Xu et al., 2017). Another prebiotic, the Chinese 
mushroom with anti-diabetic effect, Ganoderma lucidum, reduced obesity, 
inflammation in high-fat diet fed mice (Chang et al., 2015). Polyphenols from green 
tea (Wang, Zeng, et al., 2016) improved metabolic syndrome markers in mice, such 
as: reduced weight gain, adipocyte hypertrophy and liver steatosis in a dose-
dependent manner, increasing the number of butyrate-producing bacteria 
(Faecalibacterium prausnitzii, Roseburia), Bifidobacteria and Lactobacillus, acting 
as a prebiotic. A significant reduction of body and liver weight, glucose levels and 
dyslipidemia (total cholesterol, LDL and HDL-chlolesterol) was achieved in mice by 
using piceatannol, an analog of resveratrol (Tung et al., 2016). Herb formulas, like 
Chowiseungcheng-tang (CST) have anti-obesity effect by modulating the 
metabolism-related neuropeptides, adipokines and microbiota composition in mice 
(Ansari et al., 2016). Yan et al. showed that intestinal flora changed after oral gavage- 
administration of Sitagliptin in rats, leading to improvement of glucose metabolism 
and moderate correction of dysbiosis in T2DM (Yan, Feng, Li, Tang, & Wang, 
2016). Exercise vs. diet alone improved in rats the insulin resistance, reduced LDL-
cholesterol and significantly increased the abundance of cecal Streptococcaceae, 
having a weight-loss independent metabolic benefit (Welly et al., 2016). 
Improvement of metabolic endotoxemia, weight, steatosis and insulin resistance was 
achieved also by apple-derived pectin supplementation in diet-induced obese rats 
(Jiang et al., 2016) and by red pitaya fruit (Hylocereus polyrhizus) betacianins in 
mice (Song et al., 2016). Experimental studies on rats, showed that administration of 
Morinda citrifolia L. leaves extract had significant anti-obesity effect after 9 weeks 
of treatment (Gooda Sahib Jambocus et al., 2016). Composition and diversity of 
microbiota suffered beneficial changes in obesity control, both in vivo and in vitro, 
by administration of Ligustrum robustum in high-fat diet rats (Xie et al., 2015). 
Certain antibiotics, like Ceftazidime, improved the metabolic variables (glucose, 
insulin, glucagon-like peptide-1) in a dose-dependent manner in obese mice (Rajpal 
et al., 2015); co-administration of azithromycin with intestinal alkaline phosphatase 
early in life prevented the development of metabolic syndrome (Economopoulos et 
al., 2016). Similar to the frequent cannabis users, it was proven that chronic 
administration of Tetrahydrocannabiol reduced weight gain and fat mas gain in diet-
induced obese mice (Cluny, Keenan, Reimer, Le Foll, & Sharkey, 2015). Calcium 
supplementation acted also in a prebiotic manner on microbiota in obese mice 
(Chaplin, Parra, Laraichi, Serra, & Palou, 2016). Treatment of Helicobacter pylori 
infection, although the exact mechanism of action is not known yet, had a benefic 
effect on insulin resistance in mice (He et al., 2016). Dietary capsaicine, the major 
pungent bioactivator in chili peppers, prevents dysbiosis, having anti-obesity effect 
in mice (Kang et al., 2017). Prebiotic intake during lactation and pregnancy in obese 
mothers improves the metabolic profile of the offspring in rats (Paul, Bomhof, & 
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Vogel, 2016). Fecal transplant from obese to lean mice led in the latter to adopting 
the obese phenotype (Kulecka et al., 2016).  
Improvement of insulin resistance has been achieved in rats by glandular 
gastrectomy (resection of 80% of the glandular portion), even if obesity persists 
(Basso et al., 2016). Among the surgical variants of bariatric treatment, ileal 
transposition surgery showed obvious improvement of weight loss, glucose 
tolerance, increased insulin sensitivity, being a revolutionary method for obesity and 
T2DM (Oh et al., 2016). Vertical sleeve gastrectomy-induced reduction in blood 
pressure in mice shifts in gut microbiotal population, by inducing increases in the 
relative abundance of Gammaproteobacteria and Enterococcus and decreasing 





Although other reviews have already searched for possible correlations between 
microbiota and obesity, the distinct character of our review is that it comprises not 
only recent studies in human (including small children and pregnant women) and 
animal models but also therapeutic methods of treating weight gain.  
The appearance of obesity, T2DM and atherosclerosis is influenced by the 
intestinal mircrobiota (Wegielska & Suliburska, 2016). Alteration of microbiota is 
linked with a high incidence of coronary artery disease (Emoto et al., 2016); 
biomarkers of cardiovascular risk, like TMAO (trimethylamine-N-oxide) are 
dependent on microbiota (Bergeron et al., 2016). Association of dysbiosis, obesity 
and diabetes is also a higher risk of osteoporosis (Ejtahed, Soroush, Angoorani, 
Larijani, & Hasani-Ranjbar, 2016) and asthma (obesity-related asthma by alteration 
of both gastrointestinal and lung microbiota) (Cho & Shore, 2016). Dysbiosis has 
been recently demonstrated to have a role in the development and progression of 
kidney disease in obese people, so pre- and probiotics were shown in some studies 
to have benefits in improving the kidney injury (Wanchai et al., 2017).  
Alterations in the composition of microbiota can be caused by different agents 
like: industrialized food (especially higher fried food intake), combined with use of 
antibiotics, low-fiber-diets, especially lack of soluble fiber (inulin), low-bacteria 
diets (Zschocke, 2016). There have been controversies regarding azithromycin use: 
early abusive antibiotic exposure in childhood represents a damage of microbiota, 
increasing the adipogenesis (Li, Wang, et al., 2017); on the other hand, targeted use 
of simultaneous administration of azithromycin with intestinal alkaline phosphatase 
early in life prevents the development of metabolic syndrome (Economopoulos et 
al., 2016). So healthy high-fiber diet, well established meal rhythms and strategic 
intake of bacteria could reestablish the microbiota balance. Early onset of obesity 
increases the risk of obesity in adulthood.  
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Mechanisms that are involved in microbiota changes in obesity are following: 
chronic inflammation, activation of TLR4, insulin resistance, effects on bile acids, 
branched-chain amino acids (Saad, Santos, & Prada, 2016), decreased 5HT levels 
(increasing appetite) (Park et al., 2015), gastrointestinal vagal signaling (Kentish & 
Page, 2015). Pathogenesis of obesity implies changes regarding molecular 
mechanisms, including hormones like: glucagon like peptide-1, pancreatic 
polypeptide, increased ghrelin secretion (Basso et al., 2016; Perry et al., 2016) and 
cholecystokinin (Mishra, Dubey, & Ghosh, 2016). The ileal microbiota was proven 
in a study by Garidou et al. to give the outcome of metabolic disease by regulating 
Th17 cell homeostasis (Garidou et al., 2015). Another role was attributed to the 
brown fat based thermogenesis, in order to stimulate energy expenditure to reduce 
obesity (Ziętak et al., 2017). Accelerated postnatal growth in low birth-weight 
humans, with dysbiotic microbiome, leads to a higher risk of metabolic syndrome in 
adulthood than in normal birth-weight individuals (Wang, Tang, et al., 2016).  
During pregnancy, significant changes inside the microbiome take place, 
therefore alterations at this level are important to be avoided in order to have a healthy 
pregnancy (Neuman & Koren, 2017).  
It has been noticed that there are quantitative and qualitative compositional 
differences regarding gut microbiota in obese patients and healthy people; the latter 
proved to have higher abundance of Bifidobacterium spp. compared with overweight 
persons (Ignacio et al., 2016), while obese subjects have reduced numbers of 
Bacteroidetes and increased numbers of Firmicutes compared to lean people.  
Controversies regarding the implication of diversity of intestinal microbiota in 
weight gain and obesity appeared between studies on humans and animals: lower 
diversity of microbial species was shown by Park et al in a study on obese beagle 
dogs (Park et al., 2015), while another study proved by terminal restriction fragment 
length polymorphism a greater bacterial diversity and a specific composition 
(Blautia hydogenotrophica, Coprococcus catus, Ruminococcus bromii, Eubacterium 
ventriosum) in obese Japanese patients (Kasai et al., 2015).  
Experimental studies on humans and animals revealed discrepancy regarding 
implication of Lactobacillus spp. in weight induction: higher abundance of 
Lactobacillus spp. in mice was associated with whole-wheat consumption, vs. lean 
and obese mice with standard diet (Garcia-Mazcorro, Ivanov, Mills, & Noratto, 
2016); on the other hand, Ignacio et al. showed that Lactobacillus spp. were in higher 
number (p = .02) in obese and overweight children compared to the lean ones 
(Ignacio et al., 2016).  
Regarding effective strategies in order to lose weight, HPLC diets have proved 
to be for many years effective (Li, Lauber, et al., 2017), and personalized dietary 
treatments represent the future aim (Goni, Cuervo, Milagro, & Martínez, 2016). 
Many herbs proved to have prebiotic effect in order to prevent and even reduce 
obesity, physical exercise had a weight-loss independent metabolic benefit vs. diet, 
and last, but not least the bariatric surgery should be taken into account with its 
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positive results both on microbioal composition and weight loss changes. Antiviral 
agents and mycobiome manipulation would represent a new target in the therapy of 
obesity (Mar Rodríguez et al., 2015).  
High dietary polyphenol intake included in Mediterranean diet, induces a low 
risk for neurodegenerative diseases, DM, CV diseases, hypertension, obesity and 
early death (Anderson & Nieman, 2016). Parasympathetic activation can be a 
therapeutic option for obesity (Perry et al., 2016). Regular coffee consumption (3-4 
cups/day) proved to reduce the risk of developing T2DM, due to caffeine and 
chlorogenic acid content (Santos & Lima, 2016). Gallagher and LeRoith (2015) 
showed, that intentional weight loss protects against carcinogenesis, and antidiabetic 
therapy may be effective in cancer progression.  
In conclusion, implication of weight gain, obesity and gut microbiota represent 
a bidirectional effect. Any change of the quantitative and qualitative composition of 
microbiota has influence on the components of metabolic syndrome, therefore any 
management strategy for treating or preventing obesity in children and adulthood 
should have the microbiome as target. Any imbalance of microbiota composition, 
even starting from delivery mode, food diversification in children and weight gain in 
early years of life, have been proved to affect the adult's homeostasis, leading to 
obesity, and other metabolic diseases. Personalized diets, avoidance of antibiotic 
abuse, physical exercise and prebiotics would represent the most important options 
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La relación entre la microbioma intestinal y la resistencia a la insulina tiene un impacto clínico 
importante dado que la gente afectada por disbiosis tiene predisposiciones para desarrollar la 
obesidad, la diabetes mellitus tipo 2, la enfermedad de hígado graso no alcohólico, cánceres, 
enfermedades cardiovasculares, neurodegenerativas y psiquiátricas. La disbiosis puede convertirse 
en una inflamación crónica, obesidad o síndrome metabólico. Hemos hecho una revisión sistemática 
de los estudios dedicados al papel de la microbioma intestinal para el aumento de peso y la obesidad. 
Una búsqueda sistemática de datos recientes publicados en las bases de datos electrónicas se ha 
llevado a cabo usando la frase “gut microbiome and body weight and obesity”. Se ha excluido a los 
estudios que no contenían informaciones sobre la influencia de los cambios de la microbioma 
intestinal en la obesidad. La dieta occidental, uso de los antibióticos en la niñez, peso excesivo antes 
del embarazo, parto por cesárea y deficiencia de testosterona provocan la alteración de la 
microbioma y por consiguiente la apariencia de la obesidad. El predominio de firmicutes y géneros 
anaeróbicos, cambios en el microbioma y populación intestinal viral están implícitos en la etiología 
de la obesidad. Prebióticos, polifenoles, diferentes hierbas, medicamentos (antidiabéticos, calcio), 
ejercicio físico, consumo de fibras y cirugía bariátrica son las opciones terapéuticas más importantes. 
Tratamientos dietéticos personalizados, agentes antivirales y manipulación de la microbioma 
representarían nuevas metas en el tratamiento de la obesidad. Cada cambio en la composición 
cuantitativa o cualitativa de la microbioma influye en los componentes del síndrome metabólico, así 
que todas las estrategias para el tratamiento o prevención de la obesidad en niños o adultos deberían 
tener microbioma como su meta. 
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